Related Experiment Videos
Laparoscopic surgery for neuroblastoma identified by mass screening
H Yamamoto1, M Yoshida, Y Sera
1Department of Pediatric Surgery, Kumamoto University Hospital, Japan.
Journal of Pediatric Surgery
|March 1, 1996
Summary
Laparoscopic adrenalectomy is a safe and effective minimally invasive surgical option for treating neuroblastomas detected through mass screening. These screen-detected tumors often have favorable characteristics, suggesting less aggressive surgical approaches may be suitable.
Area of Science:
- Pediatric Surgery
- Oncology
- Minimally Invasive Surgery
Background:
- Neuroblastomas detected via mass screening exhibit distinct biological and epidemiological characteristics compared to clinically diagnosed tumors.
- Screen-detected neuroblastomas demonstrate favorable biological features, with a high 5-year survival rate (97%), questioning the necessity of aggressive surgical interventions.
Purpose of the Study:
- To evaluate the feasibility and outcomes of laparoscopic adrenalectomy for treating small, screen-detected neuroblastomas in infants.
- To assess the safety and efficacy of a minimally invasive surgical approach in this specific patient population.
Main Methods:
- Laparoscopic adrenalectomy was performed on three infants (one boy, two girls) with small (<20 mm) adrenal lesions.
- Procedures involved general anesthesia, five trocars, abdominal wall traction, and low intraabdominal pressure (<4 mm Hg).
- Tumor excision was completed using a containment bag, with no lymphadenopathy noted.
Main Results:
- All three patients underwent successful laparoscopic adrenalectomy with an uneventful postoperative course.
- Histological examination revealed favorable Shimada type histology and no N-myc gene amplification in the resected tumors.
- Patients remained disease-free with no recurrence or metastasis during 17–22 months of follow-up.
Conclusions:
- Laparoscopic adrenalectomy is a viable and safe surgical option for infants with select screen-detected neuroblastomas.
- The favorable biology of these tumors supports the use of minimally invasive techniques, potentially reducing surgical morbidity.